About Us Contact Us

To discuss your treatment options please call 1-800-615-3055 anytime.

Clinical Trials by Cancer Type

Learn More About This Topic: Chat with Us | Email Us

Bladder

Evaluation of Hyperthermia and Radiotherapy for the Treatment of Patients with Locally Advanced Tumors of the Pelvis

Breast

A Randomized, Phase 2 Study of the Efficacy and Tolerability of Veliparib in Combination with Temozolomide or Veliparib in Combination with Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Subjects with BRCA1 or BRCA2 Mutation and Metastatic Breast Cancer

A Phase II, Open Label, Non-Randomized, Multi-Center, Pilot, Efficacy Study of [F-18] RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Cervical

Evaluation of Hyperthermia and Radiotherapy for the Treatment of Patients with Locally Advanced Tumors of the Pelvis

Colon

A Phase I/II Study of the Safety and Biological Activity of Intraperitoneal EGEN-001 (IL-12 plasmid formulated with PEG-PEI- Cholesterol lipopolymer) Administered alone and in Combination with Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients who had Previously Received Cytoreductive Surgery plus HIPEC Therapy.

A Phase II, Open Label, Non-Randomized, Multi-Center, Pilot, Efficacy Study of [F-18] RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Lung

Randomized, Double-Blind, Multicenter, Phase 2 Trial Comparing Veliparib Plus Carboplatin and Paclitaxel versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced Non-Small-Cell Lung Cancer (NSCLC)

Protocol Numbe CMT 01-10: Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy.

A Phase II, Open Label, Non-Randomized, Multi-Center, Pilot, Efficacy Study of [F-18] RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Multiple Myeloma

A Phase I/II Study of Carfilzomib as a Replacement for Bortezomib for Multiple Myeloma Patients Failing Bortezomib-Containing Regimens

Other

A Randomized Controlled Study of YONDELIS(R)(Trabectedin) or Dacarbazine for the treatment of Advanced Liposarcoma or Leiomyosarcoma Previously Treated With an Anthracycline and Ifosfamide

Protocol ET743-SAR-3002 Phase 3b: A Multicenter, Open-Label Single Arm Study of Yondelis(R)(Trabectedin)for Subjects with Locally Advanced or Metastatic Soft Tissue Sarcoma Excluding Leiomyosarcoma and Liposarcoma Who Have Relapse or Are Refractory to Standard of Care

Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury

Ovarian

O-VAX: A Feasibility Study Using a DNP-Modified Autologous Ovarian Tumor Cell Vaccine as Therapy in Ovarian Cancer Patients After Relapse

Prostate

Sipuleucel-T (Provenge) Registry Study in Men with Advanced Prostate Cancer

Evaluation of Hyperthermia and Radiotherapy for the Treatment of Patients with Locally Advanced Tumors of the Pelvis

Rectal

Evaluation of Hyperthermia and Radiotherapy for the Treatment of Patients with Locally Advanced Tumors of the Pelvis

A Phase II, Open Label, Non-Randomized, Multi-Center, Pilot, Efficacy Study of [F-18] RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Click to have us call you

Chat Now.We're here 24/7.

First Name Last Name Email Who are you seeking
cancer care for? What type of
insurance do you have? I have read and understand the disclaimer.

Watch Cancer Videos